Matinas BioPharma Holdings, Inc.

NYSEAM:MTNB Stock Report

Market Cap: US$3.3m

Matinas BioPharma Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSEAM:MTNB Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Feb 25SellUS$190,270111 Equity Group LLCCompany206,815US$0.92
13 Feb 25SellUS$71,682Chaim HerzogIndividual100,522US$0.71

Insider Trading Volume

Insider Buying: MTNB insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of MTNB?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders141,6772.79%
Private Companies248,0004.88%
Institutions347,8396.84%
General Public4,349,46985.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.1%.

Top Shareholders

Top 25 shareholders own 14.5% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.88%
111 Equity Group LLC
248,000US$158.7k0%no data
2.09%
The Vanguard Group, Inc.
106,494US$68.2k-42.9%no data
1.85%
Herbert Conrad
93,891US$60.1k0%no data
1.26%
Sargent Investment Group, LLC
64,200US$41.1k-20%0.01%
0.98%
BlackRock, Inc.
49,650US$31.8k0%no data
0.85%
Geode Capital Management, LLC
43,467US$27.8k-6.98%no data
0.47%
Susquehanna International Group, LLP, Asset Management Arm
23,802US$15.2k0%no data
0.36%
Renaissance Technologies LLC
18,170US$11.6k0%no data
0.3%
State Street Global Advisors, Inc.
15,322US$9.8k0%no data
0.29%
Chaim Herzog
15,000US$9.6k0%no data
0.26%
James Scibetta
12,999US$8.3k0%no data
0.24%
UBS Asset Management AG
12,313US$7.9k259%no data
0.19%
Ampega Asset Management GmbH
9,600US$6.1k0%no data
0.18%
Jerome Jabbour
9,206US$5.9k0%no data
0.11%
Matthew Wikler
5,809US$3.7k0%no data
0.057%
Eric Ende
2,882US$1.8k0%no data
0.037%
Keith Kucinski
1,890US$1.2k0%no data
0.031%
Charles D. Hyman & Company
1,596US$1.0k0%no data
0.022%
Tower Research Capital Europe Limited
1,102US$705.20%no data
0.019%
Bank of America Corporation, Asset Management Arm
975US$624.1-4.04%no data
0.018%
JPMorgan Chase & Co, Brokerage and Securities Investments
904US$578.5-0.88%no data
0.0039%
Osaic Wealth, Inc. , Asset Management Arm
200US$127.90%no data
0.0028%
Morgan Stanley, Investment Banking and Brokerage Investments
144US$92.1-72.3%no data
0.002%
Wells Fargo & Company, Securities and Brokerage Investments
102US$65.4-90.7%no data
0.0012%
Steward Partners Investment Advisory, LLC
61US$39.10%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/22 02:31
End of Day Share Price 2025/02/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Matinas BioPharma Holdings, Inc. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott HenryAlliance Global Partners
Jason McCarthyMaxim Group
Yasmeen RahimiPiper Sandler Companies